Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Research Report: CSL Limited: PharmaVitae ProfileNew Pharmaceuticals research report from Datamonitor is now available from Fast Market Research
This analysis examines the historical and forecast performance for CSL in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Features and benefits * Gain insight into CSL's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source Highlights Strategic insight into the prospects for CSL over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Your key questions answered * Benchmark CSL's performance against key rivals in the prescription pharmaceutical sector* Assess the importance of the recently launched Hizentra to CSL's topline growth over the forecast period ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Report Table of Contents: Executive Summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003- Financial performance, 2003- CSL: PharmaVitae forecasts at a glance Strategic insight Acquisition of Aventis Behring made CSL a truly global player Hizentra; CSL leads the subcutaneous Ig market SWOT analysis ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly update Company introduction Company sales Company financials Data sourcing Analyst consensus QUARTERLY NEWS UPDATE Latest prescription pharma product news Q2 Q1 COMPANY INTRODUCTION Key findings Background Key corporate developments M&A history Current corporate structure COMPANY SALES Key findings Prescription pharmaceutical sales and growth rate analysis, 2003- Product analysis Product analysis, 2003- Product analysis, 2009- Therapy area analysis Geographic analysis Launch/core/ Explanation of launch/core/ Launch analysis, 2009- Core analysis, 2009- Expiry analysis, 2009- Launch/core/ Molecule type analysis Externalization analysis COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae- Operating costs and profit analysis Operating costs and profit analysis, 2003- Operating cost ratio and profit margin analysis, 2003- Operating cost ratio and profit margin analysis, 2009- Operating costs and profit analysis, 2009- APPENDIX Abbreviations Exchange rates About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|